vimarsana.com

Page 12 - ஆஸ்பென் மருந்தகம் ஹோல்டிங்ஸ் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U S Recovery Advances; N Y Tops 2 Million Cases: Virus Update

U S Recovery Advances; N Y Tops 2 Million Cases: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Japan Eyes Tokyo Emergency; India s Global Record: Virus Update

Japan Eyes Tokyo Emergency; India s Global Record: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

N Y Tops 2 Million Cases; U S Recovery Advances: Virus Update

N Y Tops 2 Million Cases; U S Recovery Advances: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Japan Eyes Tokyo Emergency; India s Global Record: Virus Update

Japan Eyes Tokyo Emergency; India s Global Record: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

South African Regulator Recommends Lifting J&J Vaccine

Word Count: 166 “These conditions include, but are not limited to, strengthened screening and monitoring of participants who are at high risk of a blood clotting disorder,” the South African Health Products Regulatory Authority said in a statement. South Africa halted J&J vaccines after health agencies on Tuesday called for their suspension in the U.S. The J&J shot is a key element to South Africa’s vaccination plan and has already been used to inoculate health workers, with no reported adverse effects. Drug maker Aspen Pharmacare Holdings Ltd. will manufacture the J&J vaccine in South Africa for wider use.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.